Covidien gains 510(k) clearance for pulse oximetry devices

05/20/2013 | RTT News

The FDA has cleared Covidien to market its Nellcor line of prescription-use pulse oximeters, designed to monitor arterial oxygen saturation in adult, pediatric, neonatal and perfused patients. The clearance applies to the Nellcor Bedside SpO2 Patient Monitoring System, the N-600x Pulse Oximetry Monitoring System and the Bedside Respiratory Patient Monitoring System.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA